What experts say about taking psilocybin as an alternative treatment for depression
Antidepressants, the gold standard treatment for depression, don’t work for many people. Will psilocybin be an alternative?
Medpage Today on MSN21h
Fast-Acting Novel Depression Tx; Lumryz Label Expanded; GLP-1s for Addiction?
News and commentary from the psychiatry world ...
FierceBiotech16h
Alto’s midphase depression trial falls flat, raising doubts about pitch to disrupt neuropsychiatry R&D
Alto Neuroscience hit a bum note in an early test of its precision neuropsychiatry model. | Alto Neuroscience hit a bum note ...
Psychology Today2d
When Depression Tells You That You're Worth Less Than Others
Research shows that when we are depressed we tend to see ourselves as less worthy of good things, which can sabotage us. What ...
Tropical depression could form as Invest 94L approaches Caribbean. Will it become Nadine?
Wind shear and mountains in Hispaniola could help protect Florida from direct impacts if Invest 94L does become Tropical ...
Bakersfield Behavioral host ‘Depression & Suicide in Older Adults’ free webinar Thursday
Bakersfield Behavioral Healthcare Hospital is hoping to save lives by spreading awareness about the dangers of suicide in a ...
YourTango1d
Workers With Depression & Mental Health Conditions Can Actually Get Accommodations At Their Job
Workers with non-visible disabilities like depression can get workplace accommodations at their jobs. Regardless of profession, employees with disabilities have a range of protections they are ...
Study links depression, outcome of sports concussion
Those who had both depression and concussion reported nearly twice as many symptoms of depression as those who had either ...
Storm tracker: System in Caribbean Sea may become tropical depression. Will it impact the US?
The National Hurricane Center said Friday it is tracking a system in the Caribbean Sea that could soon become a tropical ...
BioPharma Dive9h
Alto hits new low as depression drug flunks key test
While analysts still see value in Alto’s approach to brain drugmaking, investors may have lost some faith, as the biotech’s ...